BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 6644702)

  • 1. The tight-skin mouse: physical and biochemical properties of the skin.
    Osborn TG; Bauer NE; Ross SC; Moore TL; Zuckner J
    J Rheumatol; 1983 Oct; 10(5):793-6. PubMed ID: 6644702
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Silicone does not potentiate development of the scleroderma-like syndrome in tight skin (TSK/+) mice.
    Frondoza C; Jones L; Rose NR; Hatakeyama A; Phelps R; Bona C
    J Autoimmun; 1996 Aug; 9(4):473-83. PubMed ID: 8864822
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunological characterization of (tight skin/NZB)F1 hybrid mice with connective tissue and autoimmune features resembling human systemic sclerosis.
    Bocchieri MH; Christner PJ; Henriksen PD; Jimenez SA
    J Autoimmun; 1993 Jun; 6(3):337-51. PubMed ID: 8397715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nitric oxide synthase expression and activity in the tight-skin mouse model of fibrosis.
    Dooley A; Low SY; Holmes A; Kidane AG; Abraham DJ; Black CM; Bruckdorfer KR
    Rheumatology (Oxford); 2008 Mar; 47(3):272-80. PubMed ID: 18238792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blockade of CD40/CD40 ligand interactions attenuates skin fibrosis and autoimmunity in the tight-skin mouse.
    Komura K; Fujimoto M; Yanaba K; Matsushita T; Matsushita Y; Horikawa M; Ogawa F; Shimizu K; Hasegawa M; Takehara K; Sato S
    Ann Rheum Dis; 2008 Jun; 67(6):867-72. PubMed ID: 17823201
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation between the concentration of serum anti-topoisomerase I autoantibodies and histological and biochemical alterations in the skin of tight skin mice.
    Hatakeyama A; Kasturi KN; Wolf I; Phelps RG; Bona CA
    Cell Immunol; 1996 Jan; 167(1):135-40. PubMed ID: 8548837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mast cell accumulation and cytokine expression in the tight skin mouse model of scleroderma.
    Wang HW; Tedla N; Hunt JE; Wakefield D; McNeil HP
    Exp Dermatol; 2005 Apr; 14(4):295-302. PubMed ID: 15810888
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glycosaminoglycan content in the lung of the tight-skin mouse.
    Rosenberg GT; Ross SC; Osborn TG
    J Rheumatol; 1984 Jun; 11(3):318-20. PubMed ID: 6429328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The tight skin (Tsk) mutation in the mouse, a model for human fibrotic diseases, is tightly linked to the beta 2-microglobulin (B2m) gene on chromosome 2.
    Siracusa LD; Christner P; McGrath R; Mowers SD; Nelson KK; Jimenez SA
    Genomics; 1993 Sep; 17(3):748-51. PubMed ID: 7902327
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Animal model of sclerotic skin. II. Bleomycin induced scleroderma in genetically mast cell deficient WBB6F1-W/W(V) mice.
    Yamamoto T; Takahashi Y; Takagawa S; Katayama I; Nishioka K
    J Rheumatol; 1999 Dec; 26(12):2628-34. PubMed ID: 10606374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Collagenous abnormalities in the heart of the tight-skin mouse.
    Osborn TG; Bashey RI; Moore TL; Fischer VW
    J Mol Cell Cardiol; 1987 Jun; 19(6):581-7. PubMed ID: 3625787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transforming growth factor-beta 1 and collagen gene expression during postnatal skin development and fibrosis in the tight-skin mouse.
    Pablos JL; Everett ET; Harley R; LeRoy EC; Norris JS
    Lab Invest; 1995 Jun; 72(6):670-8. PubMed ID: 7783425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of IL-12 encoding plasmid administration on tight-skin mouse.
    Tsuji-Yamada J; Nakazawa M; Takahashi K; Iijima K; Hattori S; Okuda K; Minami M; Ikezawa Z; Sasaki T
    Biochem Biophys Res Commun; 2001 Jan; 280(3):707-12. PubMed ID: 11162578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Scleroderma-like alterations in collagen metabolism occurring in the TSK (tight skin) mouse.
    Jimenez SA; Millan A; Bashey RI
    Arthritis Rheum; 1984 Feb; 27(2):180-5. PubMed ID: 6696773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic effect of CpG-enriched plasmid administration on the tight-skin mouse model of scleroderma.
    Shen Y; Ichino M; Nakazawa M; Ikejima T; Kojima Y; Okuda K; Minami M
    J Autoimmun; 2005 May; 24(3):183-90. PubMed ID: 15848040
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of the tight-skin phenotype in immune-deficient mice.
    Dodig TD; Mack KT; Cassarino DF; Clark SH
    Arthritis Rheum; 2001 Mar; 44(3):723-7. PubMed ID: 11263788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The tight-skin mouse: is it a model for scleroderma?
    Russell ML
    J Rheumatol; 1983 Oct; 10(5):679-81. PubMed ID: 6644694
    [No Abstract]   [Full Text] [Related]  

  • 18. Glycosaminoglycan content in skin of the tight-skin mouse.
    Ross SC; Osborn TG; Dorner RW; Zuckner J
    Arthritis Rheum; 1983 May; 26(5):653-7. PubMed ID: 6847727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of skin fibrosis and autoantibodies by infusion of immunocompetent cells from tight skin mice into C57BL/6 Pa/Pa mice.
    Phelps RG; Daian C; Shibata S; Fleischmajer R; Bona CA
    J Autoimmun; 1993 Dec; 6(6):701-18. PubMed ID: 8155252
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Electron microscopic observations of elastic fibres in the lung and aorta of tight-skin and beta-aminopropionitrile-fed mice.
    Akita M; Lee SH; Kaneko K
    Histol Histopathol; 1992 Jan; 7(1):39-45. PubMed ID: 1576433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.